logo
About Contact

Anthropic Expands AI Drug Discovery with Acquisition of Innovative Biotech Startup Developing Treatments for Rare Diseases

AI News

Anthropic Expands AI Drug Discovery with Acquisition of Innovative Biotech Startup Developing Treatments for Rare Diseases

Anthropic acquires one-person biotech startup that used Claude to develop promising muscular dystrophy treatment in 18 months

Tech Startups

Anthropic acquires one-person biotech startup that used Claude to develop promising muscular dystrophy treatment in 18 months

Anthropic has acquired a biotech startup with just one full-time employee that used Claude AI to develop an experimental treatment for a rare childhood muscle disease in under 18 months, producing...

Anthropic Acquires One-Person Mithril Medicine in Major AI Drug Discovery Expansion

Techstrong

Anthropic Acquires One-Person Mithril Medicine in Major AI Drug Discovery Expansion

Anthropic has acquired one-person biotech Mithril Medicine and revealed preclinical results from Claude partnerships with Bristol Myers Squibb, Enveda, and more.

One man used Claude to find cure for rare muscle diseases, now Anthropic is buying his startup

India Today

One man used Claude to find cure for rare muscle diseases, now Anthropic is buying his startup

Professor Oak (@Prof_Oak_) October 27, 2026In a LinkedIn post, Cody Tranbarger stated that Anthropic had acquired his biotech firm in July this year. As per his LinkedIn profile,Tranbarger is an...

Anthropics’s Claude AI Helped Boosting Cancer-Fighting Cells in Lab Tests

WinBuzzer

Anthropics’s Claude AI Helped Boosting Cancer-Fighting Cells in Lab Tests

Generate Biomedicines used Anthropic's Claude AI to help redesign receptors on immune cells which kept killing cancer cells longer than usual in lab tests.

Coverage dates

First reported:

First saved on ClustZ:

Coverage updated:

We use cookies to improve your experience and analyze site traffic. By clicking "Accept", you agree to our use of cookies. See our Privacy Policy.